Although about 60% of all ovarian tumors display high expression of estrogen receptors (ER) [37], features shared between high-grade serous ovarian cancer and basal-like breast cancer (the majority of which are “triple negative”, i.e. lack expression of estrogen and progesterone receptors and HER2 amplification) have recently been reported. The gene discussed is ESR1; the disease is breast cancer.